Trial Outcomes & Findings for A Web-Based Multimedia Intervention for Head and Neck Cancer Patients (NCT NCT02442336)
NCT ID: NCT02442336
Last Updated: 2021-03-17
Results Overview
Psychological distress will be assessed using the Brief Symptom Inventory-18. The Brief Symptom Inventory-18 (BSI-18) is an 18-item scale widely used to measure psychological distress. The BSI-18 yields a total score (Global Severity Index), which is a measure of overall psychological distress. Raw scores are converted to t-scores (range 0-100) based on gender-specific normative data from cancer patient populations. A t-score of 50 is equal to the mean of the population. Higher scores represent greater levels of distress. The BSI-18 provides a clinical case-rule classifying respondents who have a t-score score ≥ 63 on the GSI as having clinically significant symptoms. Other studies have used a lower cutoff, with a GSI t-score ≥ 57 recommended as a cutoff for clinically significant symptoms in a study of cancer patients.
COMPLETED
NA
80 participants
Up to 6 weeks
2021-03-17
Participant Flow
Participant milestones
| Measure |
My Journey AHead
Several internet modules will be developed to address mouth and swallowing concerns, oral care, healthy eating, speech problems, coping with cancer, pain management, and physical therapy.
My Journey AHead: The intervention program will contain information and interactive activities around swallowing concerns, proper oral care, healthy eating and nutrition, speech issues, stress and coping with cancer, and pain management.
|
|---|---|
|
Overall Study
STARTED
|
80
|
|
Overall Study
Developmental Phase
|
6
|
|
Overall Study
Evaluation Phase
|
74
|
|
Overall Study
Provided Access to Intervention
|
55
|
|
Overall Study
COMPLETED
|
44
|
|
Overall Study
NOT COMPLETED
|
36
|
Reasons for withdrawal
| Measure |
My Journey AHead
Several internet modules will be developed to address mouth and swallowing concerns, oral care, healthy eating, speech problems, coping with cancer, pain management, and physical therapy.
My Journey AHead: The intervention program will contain information and interactive activities around swallowing concerns, proper oral care, healthy eating and nutrition, speech issues, stress and coping with cancer, and pain management.
|
|---|---|
|
Overall Study
6 patients assisted with the intervention development only.
|
6
|
|
Overall Study
Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.
|
19
|
|
Overall Study
Lost to Follow-up
|
11
|
Baseline Characteristics
A Web-Based Multimedia Intervention for Head and Neck Cancer Patients
Baseline characteristics by cohort
| Measure |
My Journey AHead
n=55 Participants
Participants were provided access to a web-base intervention that included several modules on oral care, stress and coping, nutrition, and pain management.
|
|---|---|
|
Age, Continuous
|
61.1 Years
STANDARD_DEVIATION 9.76 • n=5 Participants
|
|
Sex: Female, Male
Female
|
14 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
41 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
6 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
49 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
55 participants
n=5 Participants
|
|
Brief Symptom Inventory-18
|
67.04 units on a scale
STANDARD_DEVIATION 4.123 • n=5 Participants
|
|
Cancer Behavior Inventory (CBI-B)
|
92.25 units on a scale
STANDARD_DEVIATION 12.70 • n=5 Participants
|
PRIMARY outcome
Timeframe: Up to 6 weeksPsychological distress will be assessed using the Brief Symptom Inventory-18. The Brief Symptom Inventory-18 (BSI-18) is an 18-item scale widely used to measure psychological distress. The BSI-18 yields a total score (Global Severity Index), which is a measure of overall psychological distress. Raw scores are converted to t-scores (range 0-100) based on gender-specific normative data from cancer patient populations. A t-score of 50 is equal to the mean of the population. Higher scores represent greater levels of distress. The BSI-18 provides a clinical case-rule classifying respondents who have a t-score score ≥ 63 on the GSI as having clinically significant symptoms. Other studies have used a lower cutoff, with a GSI t-score ≥ 57 recommended as a cutoff for clinically significant symptoms in a study of cancer patients.
Outcome measures
| Measure |
Web-Based Intervention
n=44 Participants
Participants were provided access to a web-base intervention that included several modules on oral care, stress and coping, nutrition, and pain management.
|
|---|---|
|
Patient Distress
|
66.16 units on a scale
Standard Deviation 4.77
|
Adverse Events
My Journey AHead
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
My Journey AHead
n=55 participants at risk
Several internet modules will be developed to address mouth and swallowing concerns, oral care, healthy eating, speech problems, coping with cancer, pain management, and physical therapy.
My Journey AHead: The intervention program will contain information and interactive activities around swallowing concerns, proper oral care, healthy eating and nutrition, speech issues, stress and coping with cancer, and pain management.
|
|---|---|
|
Psychiatric disorders
Elevated distress
|
90.9%
50/55 • Number of events 50 • A 3- to 6-week period during which participants were on-study (i.e. consented, completed baseline assessment, provided access to the intervention, and completed program evaluation).
Adverse events due to clinical treatment or medical management of the patient's disease were not specifically collected in this behavioral study, unless the patient reported it to the study team. We did not obtain IRB approval to conduct a medical chart review for incidence of treatment-related adverse events.
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place